• Home
• About Us
• POP Guides
• Translations
• Library
• Learning Center
• POP Conference

Search: Search Entire Site Search Problem Guides Search Response Guides Search Tool Guides Crime Prevention Studies Goldstein Reports Tilley Reports

POP Center » Problems » Prescription Fraud » Endnotes

Endnotes

1. National Drug Intelligence Center (2000).[Full Text ]
2. National Drug Strategy Network (1996). [Full Text ]
3. Zickler (2001). [Full Text ]
4. Mitka (2000).
5. Mitka (2000).
6. Payne and Dabney (1997).
7. Substance Abuse and Mental Health Services Administration (2002b). [Full Text ]
8. Substance Abuse and Mental Health Services Administration (2003). [Full Text ]
9. Substance Abuse and Mental Health Services Administration (2003). [Full Text ]
10. Substance Abuse and Mental Health Services Administration (2002a). [Full Text ]
11. Palm Beach County Sheriff’s Department (2003). [Full Text ]
12. National Drug Intelligence Center (2000). [Full Text ]
13. Substance Abuse and Mental Health Services Administration (2003). [Full Text ]
14. Substance Abuse and Mental Health Services Administration (2003). [Full Text ]
15. Ramer (2001). [Full Text ]
16. National Drug Intelligence Center (2001b). [Full Text ]
17. Kalb (2001).
18. Schober (2001). [Full Text ]
19. Ramer (2001). [Full Text ]
20. Mitka (2000).
21. National Institute on Drug Abuse (2002). [Full Text ]
22. Substance Abuse and Mental Health Services Administration (2003). [Full Text ]
23. Ramer (2001). [Full Text ]
24. National Drug Intelligence Center (2000). [Full Text ]
25. National Institute on Drug Abuse (2002). [Full Text ]
26. National Institute on Drug Abuse (2002). [Full Text ]
27. National Institute on Drug Abuse (2002). [Full Text ]
28. Mitka (2000).
29. National Institute on Drug Abuse (2002). [Full Text ]
30. National Drug Intelligence Center (2000). [Full Text ]
31. Ramer (2001). [Full Text ]
32. Aiken (2001). [Full Text ]
33. U.S. Drug Enforcement Administration (2000b).[Full Text ]
34. Wilford (1990).
35. Fountain et al. (1997).
36. Fountain et al. (1997).
37. National Drug Intelligence Center (2001a). [Full Text ]
38. U.S. Drug Enforcement Administration (2000b). [Full Text ]
39. Wick (1995).
40. Clarke (1997).
41. National Association of State Controlled Substances Authorities and Alliance of States With Prescription Monitoring Programs (2002). [Full Text ]
42. UK Department of Health (1998). [Full Text ]
43. Middleton (2000). [Full Text ]
44. Joranson et al. (2002); U.S. Drug Enforcement Administration (2000a) [Full Text ]; U.S. General Accounting Office (1992[Full Text ], 2002[Full Text ]).
45. Cooper et al. (1993). [Full Text ]
46. Cooper et al. (1993). [Full Text ]
47. Forgione, Neuenschwander, and Vermeer (2001).
48. Florida Department of Law Enforcement (2001). [Full Text ]
49. Wesson and Smith(1990). [Full Text ]
50. Wessonand Smith(1990). [Full Text ]
51. Goetz (2001). [Full Text ]